OAKSIDE SURGERY — All Prescriptions & Medications — Page 6
Practice Code: L83015 | PLYMOUTH, PL5 3PY
Showing results 251-300 of 555
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lorazepam | 72 | 2,189 | £608 | -49.5% ▼ |
| 72 | 16.0K | £2.6K | +83.2% ▲ | |
| 71 | 1,014 | £2.7K | +174.0% ▲ | |
| Fentanyl | 70 | 1,006 | £3.4K | -31.7% ▼ |
| Fesoterodine fumarate | 69 | 2,828 | £620 | +74.9% ▲ |
| Metronidazole | 68 | 1,161 | £179 | +3.5% ▲ |
| Ketoconazole | 68 | 9,480 | £1.7K | -30.7% ▼ |
| 68 | 3,650 | £269 | -2.6% ▼ | |
| Co-careldopa (Carbidopa/levodopa) | 67 | 13.1K | £756 | -70.4% ▼ |
| Hydrocortisone | 67 | 5,960 | £629 | -20.6% ▼ |
| Oxybutynin | 66 | 4,336 | £1.3K | -65.4% ▼ |
| Calcium carbonate | 66 | 3,932 | £520 | +0.3% vs avg |
| Powder extensively hydrolysed formula (0913101) | 66 | 174.8K | £4.9K | -8.4% ▼ |
| Hydroxychloroquine sulfate | 66 | 3,912 | £177 | -65.9% ▼ |
| Brimonidine tartrate | 66 | 525 | £246 | +65.3% ▲ |
| Nicorandil | 65 | 5,270 | £652 | -54.8% ▼ |
| Lymecycline | 65 | 3,948 | £450 | -46.0% ▼ |
| Biphasic insulin aspart | 65 | 575 | £3.4K | -36.0% ▼ |
| Darifenacin hydrobromide | 65 | 3,164 | £2.9K | +99.4% ▲ |
| Lacosamide | 64 | 3,808 | £2.3K | +19.1% ▲ |
| Theophylline | 63 | 6,832 | £3.5K | -24.7% ▼ |
| Azithromycin | 63 | 1,986 | £625 | -50.3% ▼ |
| 62 | 10.7K | £1.1K | +28.6% ▲ | |
| Valproic acid | 61 | 5,160 | £1.6K | -29.9% ▼ |
| Fosfomycin trometamol | 61 | 75 | £347 | +114.4% ▲ |
| Insulin degludec | 61 | 371 | £4.4K | -44.5% ▼ |
| Glucose | 61 | 5,440 | £481 | +17.3% ▲ |
| Sodium bicarbonate | 61 | 7,553 | £606 | -34.0% ▼ |
| Dexamethasone | 60 | 2,328 | £1.0K | +92.5% ▲ |
| Sodium feredetate | 60 | 33.2K | £944 | +109.5% ▲ |
| 60 | 49.9K | £375 | -34.2% ▼ | |
| Desmopressin acetate | 59 | 2,597 | £2.7K | +13.1% ▲ |
| Verapamil hydrochloride | 58 | 3,752 | £524 | -36.1% ▼ |
| Ivabradine | 58 | 4,634 | £442 | -39.0% ▼ |
| 58 | 1,900 | £772 | -25.0% ▼ | |
| Glycerol | 57 | 1,194 | £187 | +62.5% ▲ |
| Quinine bisulfate | 57 | 1,820 | £331 | +46.8% ▲ |
| Semaglutide | 57 | 772 | £5.7K | -76.3% ▼ |
| Sitagliptin | 57 | 2,184 | £134 | -85.4% ▼ |
| Neomycin sulfate | 56 | 840 | £107 | -5.5% ▼ |
| 56 | 3,540 | £2.5K | +69.3% ▲ | |
| Nebivolol | 55 | 1,734 | £562 | -48.1% ▼ |
| Hydrocortisone acetate | 55 | 1,620 | £344 | -16.7% ▼ |
| 55 | 1,760 | £8.4K | +21.6% ▲ | |
| 54 | 321 | £816 | +122.9% ▲ | |
| Hydrocortisone | 53 | 1,500 | £418 | -30.2% ▼ |
| Ranolazine | 52 | 4,928 | £894 | -69.4% ▼ |
| Zonisamide | 51 | 4,284 | £2.8K | +16.9% ▲ |
| Colchicine | 51 | 3,034 | £58 | -34.6% ▼ |
| 51 | 1,915 | £1.5K | -25.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.